| Mannose receptor (CD206) activation in tumor-associated macrophages enhances adaptive and innate antitumor immune responses JM Jaynes, R Sable, M Ronzetti, W Bautista, Z Knotts, ... Science translational medicine 12 (530), eaax6337, 2020 | 230 | 2020 |
| The ferroptosis inducing compounds RSL3 and ML162 are not direct inhibitors of GPX4 but of TXNRD1 DM Cheff, C Huang, KC Scholzen, R Gencheva, MH Ronzetti, Q Cheng, ... Redox Biology 62, 102703, 2023 | 40 | 2023 |
| Testing for drug-human serum albumin binding using fluorescent probes and other methods M Ronzetti, B Baljinnyam, A Yasgar, A Simeonov Expert opinion on drug discovery 13 (11), 1005-1014, 2018 | 20 | 2018 |
| Applications of differential scanning fluorometry and related technologies in characterization of protein–ligand interactions B Baljinnyam, M Ronzetti, A Yasgar, A Simeonov Targeting enzymes for pharmaceutical development: Methods and protocols, 47-68, 2020 | 15 | 2020 |
| Dome1–JAK–STAT signaling between parasite and host integrates vector immunity and development VS Rana, C Kitsou, S Dutta, MH Ronzetti, M Zhang, Q Bernard, AA Smith, ... Science 379 (6628), eabl3837, 2023 | 13 | 2023 |
| Real-time cellular thermal shift assay to monitor target engagement TW Sanchez, MH Ronzetti, AE Owens, M Antony, T Voss, E Wallgren, ... ACS Chemical Biology 17 (9), 2471-2482, 2022 | 8 | 2022 |
| Application of biophysical methods for improved protein production and characterization: A case study on an high‐temperature requirement A‐family bacterial protease M Ronzetti, B Baljinnyam, I Jalal, U Pal, A Simeonov Protein Science 31 (12), e4498, 2022 | 7* | 2022 |
| Advances in luminescence-based technologies for drug discovery B Baljinnyam, M Ronzetti, A Simeonov Expert opinion on drug discovery 18 (1), 25-35, 2023 | 6 | 2023 |
| Mannose receptor (CD206) activation in tumor-associated macrophages enhances adaptive and innate antitumor immune responses., 2020, 12, p. eaax6337 JM Jaynes, R Sable, M Ronzetti, W Bautista, Z Knotts, ... DOI: https://doi. org/10.1126/SCITRANSLMED. AAX6337. PMID: https://www. ncbi …, 2020 | 5 | 2020 |
| Discovery of small molecule inhibitors that effectively disrupt IQGAP1-Cdc42 interaction in breast cancer cells S Sayedyahossein, J Smith, E Barnaeva, Z Li, J Choe, M Ronzetti, ... Scientific Reports 12 (1), 17372, 2022 | 4 | 2022 |
| Targeting Enzymes for Pharmaceutical Development: Methods and Protocols NE Labrou Humana Press, 2020 | 4* | 2020 |
| Controlled proteolysis of an essential virulence determinant dictates infectivity of Lyme disease pathogens M Thakur, S Bista, SD Foor, S Dutta, X Yang, M Ronzetti, VS Rana, ... Infection and Immunity 90 (5), e00059-22, 2022 | 3 | 2022 |
| Identification of activators of human fumarate hydratase by quantitative high-throughput screening H Zhu, OW Lee, P Shah, A Jadhav, X Xu, S Patnaik, M Shen, MD Hall SLAS DISCOVERY: Advancing Life Sciences R&D 25 (1), 43-56, 2020 | 3 | 2020 |
| Application of temperature-responsive HIS-tag fluorophores to differential scanning fluorimetry screening of small molecule libraries MH Ronzetti, B Baljinnyam, Z Itkin, S Jain, G Rai, AV Zakharov, U Pal, ... Frontiers in Pharmacology 13, 1040039, 2022 | 2 | 2022 |
| Abstract B49: Precision targeting of M2-like macrophages by the innate defense regulator RP-182 in pancreatic cancer and noncancerous diseases R Sable, J Jaynes, M Ronzetti, W Guzman, Z Knotts, N Val, J Morgan, ... Cancer Research 79 (24_Supplement), B49-B49, 2019 | 2 | 2019 |
| A unique borrelial protein facilitates microbial immune evasion SD Foor, K Brangulis, AK Shakya, VS Rana, S Bista, C Kitsou, M Ronzetti, ... Mbio 14 (5), e02135-23, 2023 | 1 | 2023 |
| Real-time cellular thermal shift assay (rt-cetsa) for research and drug discovery MJ Henderson, MH Ronzetti, B Baljinnyam, TW Sanchez, SG Michael, ... US Patent App. 18/020,843, 2023 | | 2023 |
| Precision targeting of M2-like macrophages by the innate defense regulator RP-182 in malignant and noncancerous diseases. RV Sable, M Ronzetti, J Jaynes, T Aiken, R Sorber, Z Knotts, D Li, ... CANCER IMMUNOLOGY RESEARCH 8 (4), 98-99, 2020 | | 2020 |
| Application of Fluorescence Technologies to High Throughput Screening Assays NPC Bolormaa Baljinnyam, Maya L. Gosztyla, Michael Ronzetti, Anton Simeonov High Throughput Screening: Methods, Techniques and Applications, 21-52, 2020 | | 2020 |
| Precision targeting of M2-like macrophages by the innate defense regulator RP-182 in pancreatic cancer and noncancerous diseases R Sable, J Jaynes, M Ronzetti, W Guzman, Z Knotts, N de Val, J Morgan, ... CANCER RESEARCH 79 (24), 2019 | | 2019 |
Anton SimeonovNational Institutes of HealthVerified email at mail.nih.gov
